UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)

UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)

90 $

Delivery time: Maximum to 1 hours

File Size = 4.33 GB

Earn 90 points worth 90 $
Category:

UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)

Our 39th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.

Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.

All sessions will be recorded and made available to participants for online viewing 30 days post course.

TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular

Objectives:

  • Providing the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
  • Refining considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
  • Applying the best considerations of surgical revascularization or percutaneous intervention for management of coronary heart disease
  • Recognizing risk stratification of cardiovascular disease
  • Optimizing the management of ascending thoracic aorta disease
  • Optimizing the management of pulmonary embolism
  • Recognizing the role of cardiac surgery in the management of endocarditis
  • Recognizing the genetic basis of cardiovascular diseases
  • Recognizing the importance of deep empathy in patient interactions
  • Recognizing that pathophysiology of diseases and treatment options differ among racial and ethnic groups
  • Optimizing the management of cardiac amyloidosis
  • Recognizing the connection between the mind and the heart
  • Recognizing the role of air pollution as a risk factor for cardiovascular diseases

Course Outline:

Friday, December 2, 2022
7:00 a.m.Registration and Continental Breakfast
8:10 a.m.Welcome and Symposium OverviewPeter Ganz, MD
Session: Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep EmpathyChair: Priscilla Hsue, MD
8:15 a.m.The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk FactorsAhmed Tawakol, MD
8:55 a.m.Artificial Intelligence in CardiologyGeoff Tison, MD, MPH
9:35 a.m.Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic TestingLisa Wilsbacher, MD, PhD
10:15 a.m.Coffee Break
10:30 a.m.Update on Transthyretin AmyloidosisMandar Aras, MD, PhD
11:10 a.m.Gene Targeting for Cardiometabolic Diseases – Where are We?John Chorba, MD
11:50 a.m.Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy MedicineEric Topol, MD
12:40 a.m.Lunch (on Your Own)
Session: State-of-the-Art: Cardiovascular InterventionsChair: Lucas Zier, MD, MS
2:00 p.m.New Approaches to Pulmonary EmbolismGregory Piazza, MD, MS
2:40 p.m.Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath LabWilliam Fearon, MD
3:20 p.m.Expanding Options in the Management of EndocarditisAmy Fiedler, MD, MS
Ann Bolger, MD
4:00 p.m.Coffee Break
4:15 p.m.Surgical Approaches to Advanced Heart FailureJason Smith, MD
4:55 p.m.Revascularization in Stable Coronary Disease: Sorting through the EvidenceJeffrey Zimmet, MD, PhD
5:35 p.m.Adjourn
Saturday, December 3, 2022
7:30 a.m.Continental Breakfast
8:05 a.m.AnnouncementsPeter Ganz, MD
Session: Advances and Controversies in ElectrophysiologyChair: Nora Goldschlager, MD
8:10 a.m.Defining Sudden Cardiac Death in 2022Zian Tseng, MD, MAS
8:50 a.m.ECG Findings Suggesting High Arrhythmic RiskMelvin Scheinman, MD
9:30 a.m.Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFibAdam Lee, MD
Tommy Dewland, MD
10:10 a.m.Coffee Break
10:25 a.m.Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and TherapyEdward Gerstenfeld, MD, MS
11:05 a.m.The Effect of Alcohol, Exercise and Lifestyle on Atrial FibrillationGregory Marcus, MD, MAS
11:45 a.m.Interventions for Novel/Genetic ArrhythmiasVasanth Vedantham, MD, PhD
12:25 p.mDebate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart FailureByron Lee, MD, MS
Joshua Moss, MD, MS
1:05 p.m.Lunch (on your own)
Session: Managing Heart FailureChair: Jonathan Davis, MD, MPHS
2:20 p.m.Cardiogenic ShockJaya Mallidi, MD
3:00 p.m.New Heart Failure Guidelines for HFrEFJonathan Davis, MD, MPHS
3:40 p.m.New Heart Failure Guidelines for HFpEFJonathan Davis, MD, MPHS
4:20 p.m.Coffee Break
4:35 p.m.Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEFAnusha McNamara, PharmD
Rose Pavlakos, PharmD
5:15 p.m.Remote Monitoring of Patients withLiviu Klein, MD, MS
Cardiovascular Diseases
5:55 p.m.Adjourn
Sunday, December 4, 2022
7:30 a.m.Continental Breakfast
8:00 a.m.AnnouncementsPeter Ganz, MD
Session: Managing Cardiovascular RiskChair: Binh An P. Phan, MD
8:05 a.m.The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart FailureMichael Crawford, MD
8:45 a.m.Managing Cardiovascular Risk in the ElderlyCarlin Long, MD
9:25 a.m.Current Cholesterol Guidelines: Controversies and AgreementsPeter Ganz, MD
10:05 a.m.Where Are We with Non-Statin Lipid Modifying Therapy?Jorge Plutzky, MD
10:45 a.m.Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with DiabetesLisa Murphy, MD, PhD
11:25 a.m.Impact of Air Pollution on CardiovascularKarol Watson, MD, PhD
Outcomes
12:05 p.m.Adjourn

Related Products